9
Views
0
CrossRef citations to date
0
Altmetric
Review

Surgical management of primary open-angle glaucoma in Africans

, &
Pages 95-107 | Published online: 09 Jan 2014

References

  • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol.90(3), 262–267 (2006).
  • Olurin O. Primary glaucoma in Nigeria. E. Afr. Med. J.49(10), 725–734 (1972).
  • Omoti AE, Akpe BA. Race and primary glaucoma. CML Ophthalmology19(1), 1–7 (2009).
  • Murdoch IE, Cousens SN, Babalola OE, Yang YF, Abiose A, Jones BR. Glaucoma prevalence may not be uniformly high in all ‘black’ populations. Afr. J. Med. Sci.30(4), 337–339 (2001).
  • Ekwerekwu CM, Umeh RE. The prevalence of glaucoma in an onchoendemic community in south-eastern Nigeria. West Afr. J. Med.21(3), 200–203 (2002).
  • Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S et al. Prevalence of glaucoma in an African population. Eye18(5), 491–497 (2004).
  • Rotchford AP, Johnson GJ. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch. Ophthalmol.120(4), 471–478 (2002).
  • Buhrman RR, Quigley HA, Barron Y, West SK, Oliva MS, Mmbaga BB. Prevalence of glaucoma in a rural East African population. Invest. Ophthalmol. Vis. Sci.41(1), 40–48 (2000).
  • Rotchford AP, Johnson GJ. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology110(2), 376–382 (2003).
  • Cook C. Glaucoma in Africa: size of the problem and possible solutions. J. Glaucoma18(2), 124–128 (2009).
  • Cedrone C, Mancina R, Cerulli A et al. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog. Brain. Res.173, 3–14 (2008).
  • Tielsch JM, Sommer A, Katz J et al. Racial variations in the prevalence of primary open angle glaucoma. The Baltimore Eye Survey. JAMA266(3), 396–474 (1991).
  • Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye study. Prevalence of open-angle glaucoma. Arch. Ophthalmol.112(6), 821–829 (1994).
  • Murdoch I. Epidemiology and primary open-angle glaucoma. Community Eye Health9(18), 19–22 (1996).
  • Cowan CL, Worthem DM, Mason RP, Anduze AL. Glaucoma in blacks (editorials). Arch. Ophthalmol.106(6), 738–739 (1988).
  • Egbert PR. Glaucoma in West Africa: a neglected problem. Br. J. Ophthalmol.86(2), 131–132 (2002).
  • Rabiu MM. Prevalence of blindness and low vision in north central, Nigeria. West Afr. J. Med.27(4), 238–244 (2008).
  • Sherwin JC, Dean EH, Metcalfe NH. Causes of blindness at Nkhoma Eye Hospital, Malawi. Eur. J. Ophthalmol.18(6), 1002–1006 (2008).
  • Onakpoya OH, Adeoye AO, Akinsola FB, Adegbehingbe BO. Prevalence of blindness and visual impairment in Atakunmosa West Local Government area of southwestern Nigeria. Tazan. Health. Res. Bull.9(2), 126–131 (2007).
  • Guzek JP, Anyomi FK, Fiadoyor S, Nyonator F. Prevalence of blindness in people over 40 years in the Volta region of Ghana. Ghana Med. J.39(2), 55–62 (2005).
  • Babalola OE, Maegga B, Katenga S et al. APOC impact assessment studies: baseline ophthalmological findings in Morogoro, Tanzania. Afr. J. Med. Med. Sci.37(4), 327–332 (2008).
  • Schemann JF, Inocencio F, de Lourdes Monteiro M, Andrade J, Auzemery A, Guelfi Y. Blindness and low vision in Cape Verde Islands: results of a national eye survey. Ophthalmic Epidemiol.13(4), 219–226 (2006).
  • Zerihun N, Mabey D. Blindness and low vision in Jimma Zone, Ethiopia: results of a population-based survery. Ophthalmic Epidemiol.4(1), 19–26 (1997).
  • Whitfield R, Schwab L, Ross-Degnan D et al. Blindness and eye disease in Kenya: ocular status survey results from the Kenya Rural Blindness Prevention Project. Br. J. Ophthalmol.74(6), 333–340 (1990).
  • Faal H, Minassian D, Sowa S et al. National survey of blindness and low vision in the Gambia: results. Br. J. Ophthalmol.73(2), 82–87 (1989).
  • Cook CD, Knight SE, Crofton-Briggs I. Prevalence and causes of low vision and blindness in northern KwaZulu. S. Afr. Med. J.83(8), 590–593 (1993).
  • Balo K, Negrel DA. Les causes de cécité au Togo. J. Fr. Ophtalmol.12(4), 291–295 (1989).
  • Négrel A-D, Avognon Z, Minassian DC et al. La cécité au Benin. Med. Trop.55(4), 409–414 (1995).
  • Omoti AE, Osahon AI, Waziri-Erameh MJM. Pattern of presentation of primary open-angle glaucoma in Benin city, Nigeria. Trop. Doct.36(2), 97–100 (2006).
  • Omoti AE, Waziri-Erameh MJM. Compliance with medical therapy in patients with primary open-angle glaucoma. J. Med. Biomed. Res.2(1), 46–53 (2003).
  • Omoti AE, Ukponmwan CU. Compliance with new drugs in glaucoma therapy in Benin-city, Nigeria. Seguimiento Farmacoterapeutico3(3), 135–143 (2005).
  • Omoti AE. A review of the choice of therapy in primary open-angle glaucoma. Nig. J. Clin. Pract.8(9), 29–34 (2005).
  • Taylor J. Primary surgical treatment of glaucoma. Community Eye Health9(19), 33–34 (1996).
  • AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am. J. Ophthalmol.132(3), 311–320 (2001).
  • Schwartz AL, Love DC, Schwartz MA. Long-term followup of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch. Ophthalmol.103(10), 1482–1484 (1985).
  • Krupin T, Patkin R, Kurata FK et al. Argon laser trabeculoplasty in black and white patients with open-angle glaucoma. Ophthalmology93(6), 811–816 (1986).
  • Welsh NH. Failure of filteration operations in the African. Br. J. Ophthalmol.54(9), 594–598 (1970).
  • Cairns LE. Trabeculectomy: preliminary report of a new method. Am. J. Ophthalmol.66(4), 673–679 (1968).
  • Watson PG. Trabeculectomy, a modified ab externo technique. Ann. Ophthalmol.2, 199–205 (1970).
  • Wilson RM. Posterior lip sclerectomy vs trabeculectomy in Western Indian blacks. Arch. Ophthalmol.107(11), 1604–1608 (1989).
  • Shaffer RN. The centennial history of glaucoma (1896–1996). American Academy of Ophthalmology. Ophthalmology103(8 Suppl.), S40–S50 (1996).
  • Sharir M, Zimmerman TJ. II. Initial treatment of glaucoma; medical therapy. Surv. Ophthalmol.37(4), 299–304 (1993).
  • Hitchings RA. Trabeculectomy – the golden standard. In: Glaucoma Therapy. Current Issues and Controversies. Shaarawy T, Flammer J (Eds). Martin Dunitz, London, UK, 249–255 (2004).
  • Singh K, Egbert PR, Byrd S et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am. J. Ophthalmol.123(1), 48–53 (1997).
  • Mietz H, Krieglstein GK. Suramin to enhance glaucoma filtering procedures: a clinical comparison with mitomycin. Ophthalmic Surg. Lasers32(5), 358–359 (2001).
  • Kolker AE, Kass MA, Rait JL. Trabeculectomy with releasable sutures. Trans. Am. Ophthalmol. Soc.91, 131–141 (1993).
  • Simsek T, Citirik M, Batman A, Mutevelli S, Zilelioglu O. Efficacy and complications of releasable suture trabeculectomy and standard trabeculectomy. Int. Ophthalmol.26(1–2), 9–14 (2005).
  • Aykan U, Bilge AH, Akin T, Certel I, Bayer A. Laser suture lysis or releasable sutures after trabeculectomy. J. Glaucoma16(2), 240–245 (2007).
  • Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. II. Variations in operative technique and outcome. Eye15(Pt 4), 441–448 (2001).
  • Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye16(3), 297–303 (2002).
  • Stalmans I, Gillis A, Lafaut AS, Zeyen T. Safe trabeculectomy technique: long term outcome. Br. J. Ophthalmol.90(1), 44–47 (2006).
  • Wells AP, Bunce C, Khaw PT. Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery. J. Glaucoma13(5), 400–406 (2004).
  • Ophir I, Pikkel J. Mini-trabeculectomy in eyes with high risk of scarring: midterm follow-up. Am. J. Ophthalmol.131(1), 13–18 (2001).
  • Labbé A, Lachkar Y, Cohn H. Efficacy and complications of a mini-trabeculectomy technique. J. Fr. Ophtalmol.31(5), 481–488 (2008).
  • Lai JS, Lam DS. Trabeculectomy using a sutureless scleral tunnel technique: a preliminary study. J. Glaucoma8(3), 188–192 (1999).
  • Eslami Y, Fakhraie G, Amini H et al. The results of trabeculectomy using a sutureless scleral tunnel technique. Int. Ophthalmol.29(5), 329–332 (2009).
  • Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst. Rev.(1), CD002897 (2001).
  • Martini E, Laffi GL, Sprovieri C, Scorolli L. Low-dosage mitomycin C as an adjunct to trabeculectomy. A prospective controlled study. Eur. J. Ophthalmol.7(1), 40–48 (1997).
  • Wormald R, Wilkins MR, Bunce C. Post-operative 5-fluorouracil for glaucoma surgery. Cochrane Database Syst. Rev.(3), CD001132 (2001).
  • Ophir A, Ticho U. A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Arch. Ophthalmol.110(8), 1072–1075 (1992).
  • Leyland M, Bloom P, Zinicola E, McAlister J, Rassam S, Migdal C. Single intraoperative application of 5-fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial. J. Glaucoma10(6), 452–457 (2001).
  • Costa VP, Wilson RP, Moster MR, Schmidt CM, Gandham S. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic. Surg.24(6), 389–394 (1993).
  • Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am. J. Ophthalmol.116(3), 314–326 (1993).
  • Kupin TH, Juzych MS, Shin DH, Khatana AK, Olivier MM. Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am. J. Ophthalmol.119(1), 30–39 (1995).
  • Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch. Ophthalmol.116(4), 443–447 (1998).
  • Soltau JB, Rothman RF, Budenz DL et al. Risk factors for glaucoma filtering bleb infections. Arch. Ophthalmol.118(3), 338–342 (2000).
  • Jampel HD, Quigley HA, Kerrigan-Baumrind LA, Melia BM, Friedman D, Barron Y; Glaucoma Surgical Outcomes Study Group. Risk factors for late-onset infection following glaucoma filtration surgery. Arch. Ophthalmol.119(7), 1001–1008 (2001).
  • Whiteside-Michel J, Liebmann JM, Ritch R. Initial 5-fluorouracil trabeculectomy in young patients. Ophthalmology99(1), 7–13 (1992).
  • Suner IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF. Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology104(2), 207–214 (1997).
  • Scott DR, Quigley HA. Medical management of a high bleb phase after trabeculectomies. Ophthalmology95(9), 1169–1173 (1988).
  • Ederer F, Gaasterland DA, Dally LG et al.; The AGIS Investigators. The Advanced Glaucoma Intervention study (AGIS). 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology111(4), 651–664 (2004).
  • Heuer DK, Gressel MG, Parrish RK 2nd, Anderson DR, Hodapp E, Palmberg PF. Trabeculectomy in aphakic eyes. Ophthalmology91(9), 1045–1051 (1984).
  • Gross RL, Feldman RM, Spaeth GL et al. Surgical therapy of chronic glaucoma in aphakia and pseudophakia. Ophthalmology95(9), 1195–1201 (1988).
  • Lichter PR, Musch DC, Gillespie BW et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology108(11), 1943–1953 (2001).
  • Shirato S, Kitazawa Y, Mishima S. A critical analysis of the trabeculectomy results by a prospective follow-up design. Jpn. J. Ophthalmol.26(4), 468–480 (1982).
  • AGIS (Advanced Glaucoma Intervention Study) Investigators. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch. Ophthalmol.119(12), 1771–1779 (2001).
  • Hylton C, Congdon N, Friedman D et al. Cataract after glaucoma filtration surgery. Am. J. Ophthalmol.135(2), 231–232 (2003).
  • The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am. J. Ophthalmol.121(4), 349–366 (1996).
  • Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor b2 antibody: a new glaucoma antiscarring agent. Invest. Ophthalmol. Vis. Sci.40(10), 2225–2234 (1999).
  • Kirwan JF, Cousens S, Venter L et al. Effect of b radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial. Br. Med. J.333(7575), 942 (2006).
  • Omoti AE, Edema OT, Waziri-Erameh MJM. Acceptability of surgery as initial treatment for primary open-angle glaucoma. J. Med. Biomed. Res.1(1), 68–74 (2002).
  • Bekibele CO, Oluleye TS. Acceptability of surgery for primary treatment of chronic open-angle glaucoma. A preliminary report. Niger. J. Ophthalmol.7(1), 5–9 (1999).
  • Feldman RM, Tabet RR. Needle revision of filtering blebs. J. Glaucoma17(7), 594–600 (2008).
  • Pastemack JJ, Wand M, Shields MB, Abraham D. Needle revision of failed filtering blebs using 5-fluorouracil and a combined ab-externo and ab-interno approach. J. Glaucoma14(1), 47–51 (2005).
  • Fargeli M, Løfors KT, Elsås T. Needling revision of failed filtering blebs after trabeculectomy: a retrospective study. Acta Ophthalmol.81(6), 577–582 (2003).
  • Wishart PK. Trabeculectomy is not the best surgical option for glaucoma. Eye22(5), 603–606 (2008).
  • DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch. Ophthalmol.120(3), 297–300 (2002).
  • Musch DC, Gillespie BW, Niziol LM et al. Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch. Ophthalmol.124(12), 1694–1700 (2006).
  • Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am. J. Ophthalmol.143(1), 9–22 (2007).
  • Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am. J. Ophthalmol.143(1), 23–31 (2007).
  • Agbeja-Bayeroju AM, Omoruyi M, Owoaje ET. Effectiveness of trabeculectomy on glaucoma patients in Ibadan. Afr. J. Med. Sci.30(1–2), 39–42 (2001).
  • Adegbehingbe BO, Majemgbasan T. A review of trabeculectomies at a Nigerian teaching hospital. Ghana Med. J.41(4), 176–180 (2007).
  • Freedman J, Shen E, Ahrens M. Trabeculectomy in a black American glaucoma population. Br. J. Ophthalmol.60(8), 573–574 (1976).
  • Quigley HA, Buhrmann RR, Isseme I, Scudder M, Oliva MS. Long term results of glaucoma surgery among participants in an east African population survey. Br. J. Ophthalmol.84(8), 860–864 (2000).
  • Mielke C, Dawda VK, Anand N. Intra-operative 5-fluorouracil application during primary trabeculectomy in Nigeria: a comparative study. Eye17(7), 829–834 (2003).
  • Kim HY, Egbert PR, Singh K. Long-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West Africa. J. Glaucoma17(7), 578–583 (2008).
  • Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in East Africa. Br. J. Ophthalmol.85(9), 1028–1030 (2001).
  • Bekibele CO. Evaluation of 56 trabeculectomy operations at Ago-Iwoye, Ogun State, Nigeria. West. Afr. J. Med.20(3), 223–226 (2001).
  • Krasnov MM. Externalization of Schlemm’s canal (sinusotomy) in glaucoma. Br. J. Ophthalmol.52(2), 157–162 (1968).
  • Shaarawy T, Mermoud A. Deep sclerectomy (or the words of Hiraclitus). In: Glaucoma Therapy. Current issues and Controversies. Shaarawy T, Flammer J (Eds). Martin Dunitz, London, UK, 257–268 (2004).
  • Fyodorov SN, Ioffe DI, Ronkina TI. Glaucoma surgery-deep sclerectomy. Vestn. Oftamol.4, 6–10 (1982).
  • Zimmerman TJ, Kooner KS, Ford VJ et al. Effectiveness of non-penetrating trabeculectomy in aphakic patients with glaucoma. Ophthalmic. Surg.15(1), 44–50 (1984).
  • Stegman R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J. Cataract. Refract. Surg.25(3), 316–322 (1999).
  • Hondur A, Onol M, Hasanreisoglu B. Nonpenetrating glaucoma surgery: meta-analysis of recent results. J. Glaucoma17(7), 139–146 (2008).
  • Yuan ZL, Yang Q, Chen Q, Zhang WZ, Sun H. Modified viscocanalostomy for the surgical treatment with primary open-angle glaucoma. Zhonghua Yan Ke Za Zhi43(5), 421–425 (2007).
  • Yarangümeli A, Güreser S, Köz OG, Elhan AH, Kural G. Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma. Int. Ophthalmol.25(4), 207–213 (2004).
  • Cheng JW, Ma XY, Wei RL. Efficacy of non-penetrating trabecular surgery for open-angle glaucoma: a meta-analysis. Chin. Med. J. (Engl.)117(7), 1006–1010 (2004).
  • Goldsmith JA, Ahmed IK, Crandall AS. Nonpenetrating glaucoma surgery. Ophthalmol. Clin. North. Am.18(3), 443–460 (2005).
  • Mielke C, Dawda VK, Anand N. Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in West Africa. Br. J. Ophthalmol.90(3), 310–313 (2006)
  • Valimaki J, Shaarawy T, Airaksinen PJ. Glaucoma drainage implants. In: Glaucoma Therapy.Current Issues and Controversies. Shaarawy T, Flammer J (Eds). Martin Dunitz, London, UK, 275–289 (2004).
  • Minckler DS, Francis BA, Hodapp EA et al. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology115(6), 1089–1098 (2008).
  • Tarkkanen A, Puska P, Kivela T. Cyclodestruction in the treatment of glaucoma. In: Glaucoma Therapy.Current Issues and Controversies. Shaarawy T, Flammer J (Eds). Martin Dunitz, London, UK, 227–237 (2004).
  • Pastor SA, Singh K, Lee DA, Juzych MS, Netland PA, Nguyen NT. Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology108(11), 2130–2138 (2001).
  • Youn J, Cox TA, Allingham RR, Shields MB. Factors associated with visual acuity loss after noncontact transscleral Nd:YAG cyclophotocoagulation. J. Glaucoma5(6), 390–394 (1996).
  • Bechrakis NE, Muller-Stolzenburg NW, Helbig H, Foerster MH. Sympathetic ophthalmia following laser cyclocoagulation. Arch. Ophthalmol.112(1), 80–84 (1994).
  • Grueb M, Rohrbach JM, Bartz-Schmidt KU, Schlote T. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes. Graefes Arch. Clin. Exp. Ophthalmol.244(10), 1293–1299 (2006).
  • Egbert PR, Fiadoyor S, Budenz DL, Dadzie P, Byrd S. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch. Ophthalmol.119(3), 345–350 (2001).
  • Lewis RA, von Wolff K, Tetz M et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J. Cataract Refract. Surg.33(7), 1217–1226 (2007).
  • Shingleton B, Tetz M, Korber N. Circumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year results. J. Cataract Refract. Surg.34(3), 433–440 (2008).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.